Clinical Trials Search Results

Results 1-10 of 86 for your search
Show Search Criteria
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 828 locations
Sorafenib with or without Everolimus in Treating Patients with Advanced, Radioactive Iodine Refractory Thyroid Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 22 locations
Neratinib HER Mutation Basket Study (SUMMIT)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 19 locations
Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
Status: Active
Age: Not specified
Gender: Male or Female
Location: 20 locations
1 2 3 ... 9 Next >